CVS Health Corporation (CVS)

CVS Health's stock experienced several notable events in the past six months. In Q1 2026, the company reported strong earnings, surpassing expectations and raising its full-year adjusted EPS guidance, leading to a stock price surge. CVS Health consistently pays quarterly dividends. The stock experienced a decline due to regulatory scrutiny surrounding pharmacy benefit managers (PBMs) and a proposed class action lawsuit. CVS Health reported an increase in total revenues for Q4 and full-year 2025. At its Investor Day 2025, CVS Health updated its financial guidance and committed to a mid-teens Adjusted EPS compound annual growth rate through 2028. The acquisition of Rite Aid assets positively impacted prescription volume and revenue in Q1 2026.

Demand for CVS Health's products and services exhibits seasonality, with a significant portion of sales occurring during major seasonal moments like Christmas, Halloween, Easter, and Valentine's Day. Summer demand also contributes to increased sales. ExtraCare members actively engage with rewards and visit CVS stores reliably during these periods.

CVS Health Corp. is a multinational healthcare company operating in pharmacies & drug stores, health & medical insurance, pharmacy benefit management (PBM), and dental insurance. The company provides integrated healthcare solutions to improve access, lower costs, and act as a trusted health partner. CVS Pharmacy retail stores provide prescription drugs and health and wellness products. CVS Caremark processes billions of prescription claims annually, offering PBM solutions. Through the acquisition of Aetna, CVS Health operates as a health insurer. The company also delivers healthcare through CVS MinuteClinic, CVS Specialty, Oak Street Health, and Signify Health. CVS Health offers branded and generic prescription drugs, nonprescription medicines, and personal health supplies.

CVS Health's operations and customer base are primarily in the United States. The company has over 9,000 retail locations across 52 states and territories, serving 3,393 cities. Its corporate headquarters is in Woonsocket, Rhode Island, with other key hubs in Irving, Texas; Chicago, Illinois; and Scottsdale, Arizona.

CVS Health's brand reputation has been shaped by positive initiatives and challenges. CVS Pharmacy began a brand refresh for its private-label products, and a high percentage of Americans trust CVS Health brand products. The company continues its commitment to social justice, health equity, public health initiatives, and efforts to combat smoking and prescription drug abuse. CVS Health won Stevie Awards for Enterprise AI and Customer Experience AI, and CVS Caremark expanded biosimilar adoption. The company's PBM practices have faced scrutiny, including allegations of anticompetitive conduct. Concerns about unsafe workplace claims, staffing levels, and working conditions have impacted reputation, and CVS Pharmacy employees in Southern California went on strike over demands for better pay and staffing conditions.

CVS Health Corporation's ownership is predominantly held by institutional investors, who collectively own approximately 80% to 88% of the outstanding shares. The largest shareholders are Vanguard Group, BlackRock Inc., and State Street Corporation. Insiders own less than 1% of the company's shares, while the general public holds around an 11% stake. Glenview Capital Management acquired an activist stake in late 2024, securing board representation.